Long-Term Safety of Extremely Low-Dose Amiodarone at 50 mg Daily in Patients With Persistent Atrial Fibrillation.

J Arrhythm · 2025 · PMC12270819 · PMID 40687632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Also, selection bias may be significant, especially in evaluating the efficacy of amiodarone therapy because this was a retrospective study primarily designed to evaluate the safety of rather than the efficacy of amiodarone therapy.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.